Global Angiotensin Converting Enzyme (ACE) Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

An angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure.

SCOPE OF THE REPORT:

The worldwide market for Angiotensin Converting Enzyme (ACE) Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Angiotensin Converting Enzyme (ACE) Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Abbott Laboratories
• Pfizer
• Novartis
• Merck
• Astra Zeneca
• Jhonson and Johnson
• Eli Lilly and Company
• Sanofi SA
• Bristol-Myers Squibb
• Bayer
• GSK
• Teva Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Sulfhydryl-containing Agents
• Dicarboxylate-containing Agents
• Phosphonate-containing Agents

Market Segment by Applications, can be divided into

• Hypertension
• Cardiovascular Diseases
• Kidney Diseases
• Other

There are 15 Chapters to deeply display the global Angiotensin Converting Enzyme (ACE) Inhibitors market.

Chapter 1, to describe Angiotensin Converting Enzyme (ACE) Inhibitors Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors, with sales, revenue, and price of Angiotensin Converting Enzyme (ACE) Inhibitors, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Angiotensin Converting Enzyme (ACE) Inhibitors, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Angiotensin Converting Enzyme (ACE) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Angiotensin Converting Enzyme (ACE) Inhibitors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

LIST OF TABLES AND FIGURES

Figure Angiotensin Converting Enzyme (ACE) Inhibitors Picture
Table Product Specifications of Angiotensin Converting Enzyme (ACE) Inhibitors
Figure Global Sales Market Share of Angiotensin Converting Enzyme (ACE) Inhibitors by Types in 2017
Table Angiotensin Converting Enzyme (ACE) Inhibitors Types for Major Manufacturers
Figure Sulfhydryl-containing Agents Picture
Figure Dicarboxylate-containing Agents Picture
Figure Phosphonate-containing Agents Picture
Figure Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Applications in 2017
Figure Hypertension Picture
Figure Cardiovascular Diseases Picture
Figure Kidney Diseases Picture
Figure Other Picture
Figure United States Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure France Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure UK Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure China Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure India Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (Value) and Growth Rate (2013-2023)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Eli Lilly and Company Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi SA Basic Information, Manufacturing Base and Competitors
Table Sanofi SA Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Sanofi SA Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Type and Applications
Table Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Manufacturer (2016-2017)
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Manufacturer in 2016
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Manufacturer in 2017
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturer (2016-2017)
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Manufacturer in 2016
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Manufacturer in 2017
Figure Top 3 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturer (Revenue) Market Share in 2017
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Regions (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Regions (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Regions (2013-2018)
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Regions in 2013
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Regions in 2017
Figure North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2013-2018)
Table North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2013-2018)
Table North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2013-2018)
Figure North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries in 2013
Figure North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries in 2017
Table North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2013-2018)
Table North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2013-2018)
Figure North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2013
Figure North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2017
Figure United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Canada Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2013-2018)
Table Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2013-2018)
Table Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2013-2018)
Table Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2013-2018)
Figure Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2016
Figure Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2017
Figure Germany Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure UK Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure France Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Russia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Italy Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2013-2018)
Table Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries 2017
Table Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2013-2018)
Figure Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries 2017
Figure China Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Korea Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure India Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2013-2018)
Table South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2013-2018)
Table South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2013-2018)
Figure South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries in 2017
Table South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2013-2018)
Table South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2013-2018)
Figure South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2017
Figure Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Colombia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Countries (2013-2018)
Table Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Countries in 2017
Table Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Countries (2013-2018)
Table Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2013
Figure Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Countries in 2017
Figure Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure UAE Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Egypt Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure Nigeria Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Figure South Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Growth Rate (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Type (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Type (2013-2018)
Figure Global Sulfhydryl-containing Agents Sales Growth (2013-2018)
Figure Global Sulfhydryl-containing Agents Price (2013-2018)
Figure Global Dicarboxylate-containing Agents Sales Growth (2013-2018)
Figure Global Dicarboxylate-containing Agents Price (2013-2018)
Figure Global Phosphonate-containing Agents Sales Growth (2013-2018)
Figure Global Phosphonate-containing Agents Price (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2013-2018)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Application (2013-2018)
Figure Global Cardiovascular Diseases Sales Growth (2013-2018)
Figure Global Kidney Diseases Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Growth Rate (2018-2023)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Regions (2018-2023)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Regions (2018-2023)
Figure North America Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2018-2023)
Figure Europe Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2018-2023)
Figure Asia-Pacific Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2018-2023)
Figure South America Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2018-2023)
Figure Middle East and Africa Sales Angiotensin Converting Enzyme (ACE) Inhibitors Market Forecast (2018-2023)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Type (2018-2023)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Type (2018-2023)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Application (2018-2023)
Table Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List